Opening Bell Analysts Research Calls for Monday, March 27
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Fortive (FTV) upgraded to Buy from Hold at Vertical Research; tgt $74
> HeidelbergCement (HDELY) upgraded to Buy from Hold at Jefferies
> J.M. Smucker (SJM) upgraded to Buy from Hold at Argus; tgt $170
> Renault (RNSDF) upgraded to Buy from Hold at HSBC Securities
Downgrades:
> Berkshire Grey (BGRY) downgraded to Hold from Buy at Craig Hallum; tgt lowered to $1.40
> CyberAgent (CYGIY) downgraded to Sell from Neutral at Citigroup
> Pernod-Ricard (PDRDY) downgraded to Neutral from Overweight at JP Morgan
> Roche Hldg (RHHBY) downgraded to Equal Weight from Overweight at Barclays
Others:
> Autolus Therapeutics (AUTL) assumed with an Overweight at Wells Fargo; tgt $8
> Fate Therapeutics (FATE) assumed with an Equal Weight at Wells Fargo; tgt $6
> FedEx (FDX) initiated with a Hold at Melius; tgt $240
> Fisker (FSR) placed on Catalyst Watch at Citigroup
> Gracell Biotechnologies (GRCL) assumed with an Overweight at Wells Fargo; tgt $7
> Iovance Biotherapeutics (IOVA) assumed with an Equal Weight at Wells Fargo; tgt $11
> Lion Electric (LEV) initiated with a Buy at R. F. Lafferty; tgt $7
> UPS (UPS) initiated with a Buy at Melius; tgt $225
Contact [email protected] for any questions or corrections.